ABCL Logo

AbCellera Biologics Inc. (ABCL) 

NASDAQ$2.52
Market Cap
$750.93M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
114 of 924
Rank in Industry
79 of 527

ABCL Insider Trading Activity

ABCL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,680,2884100
Sells
$000

Related Transactions

Thermopylae Holdings Ltd.10 percent owner2$1.48M0$0$1.48M
Montalbano John S.director2$198,0680$0$198,068

About AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is â€¦

Insider Activity of AbCellera Biologics Inc.

Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $1.68M and sold $0 worth of AbCellera Biologics Inc. stock.

On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $30.23M and sold $394.03M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Thermopylae Holdings Ltd. (10 percent owner) — $1.48M. Montalbano John S. (director) — $198,068.

The last purchase of 343,631 shares for transaction amount of $742,243 was made by Thermopylae Holdings Ltd. (10 percent owner) on 2025‑03‑11.

List of Insider Buy and Sell Transactions, AbCellera Biologics Inc.

2025-03-11PurchaseThermopylae Holdings Ltd.10 percent owner
343,631
0.1117%
$2.16$742,243+7.62%
2025-03-10PurchaseMontalbano John S.director
25,000
0.0088%
$2.30$57,500+7.95%
2025-03-06PurchaseMontalbano John S.director
60,000
0.0198%
$2.34$140,568-1.89%
2024-08-29PurchaseThermopylae Holdings Ltd.10 percent owner
283,516
0.0993%
$2.61$739,977+10.67%
2023-11-08PurchaseMontalbano John S.director
10,000
0.0037%
$4.46$44,600-7.89%
2023-11-06PurchaseMontalbano John S.director
20,000
0.0071%
$4.64$92,800-13.76%
2023-09-22PurchaseHayden Michael Rdirector
20,000
0.0066%
$4.91$98,200-14.30%
2023-09-12PurchaseLecault VeroniqueChief Operating Officer
20,000
0.007%
$5.19$103,800-15.56%
2023-08-08PurchaseHayden Michael Rdirector
30,000
0.0104%
$5.90$177,000-23.77%
2023-05-26PurchaseThermopylae Holdings Ltd.10 percent owner
153,000
0.051%
$6.52$997,728-26.25%
2023-05-26PurchaseBooth AndrewChief Financial Officer
14,500
0.0051%
$6.85$99,325-26.25%
2022-12-16PurchaseThermopylae Holdings Ltd.director
85,102
0.0295%
$10.10$859,249-33.50%
2022-08-19PurchaseThermopylae Holdings Ltd.10 percent owner
200,000
0.0702%
$11.46$2.29M-20.94%
2022-06-14PurchaseThermopylae Holdings Ltd.10 percent owner
9,173
0.0029%
$8.05$73,842+16.48%
2022-06-13PurchaseThermopylae Holdings Ltd.10 percent owner
54,915
0.0189%
$8.03$441,066+25.00%
2022-06-06PurchaseThermopylae Holdings Ltd.10 percent owner
64,545
0.0222%
$7.50$483,965+33.64%
2022-05-16PurchaseLecault VeroniqueChief Operating Officer
200,000
0.057%
$6.34$1.27M+31.24%
2022-05-13PurchaseThermopylae Holdings Ltd.10 percent owner
300,000
0.1057%
$7.26$2.18M+41.77%
2022-05-12PurchaseThermopylae Holdings Ltd.10 percent owner
1.41M
0.4723%
$6.41$9.02M+52.76%
2022-05-12PurchaseBooth AndrewChief Financial Officer
85,000
0.0258%
$5.79$492,150+52.76%
Total: 40
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Thermopylae Holdings Ltd.10 percent owner
56143640
18.8409%
$141.48M111+6.35%
Montalbano John S.director
171000
0.0574%
$430,920.0080<0.0001%
THIEL PETERdirector
10179880
3.4162%
$25.65M10<0.0001%
Lecault VeroniqueChief Operating Officer
2040122
0.6846%
$5.14M41<0.0001%
Hayden Michael Rdirector
1323397
0.4441%
$3.33M31<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$3,596,906
112
13.42%
$635.29M
$7,929,017
58
21.56%
$787.18M
$97,176
41
42.84%
$802.16M
$94,912,877
34
-7.15%
$626.42M
$61,752,931
34
14.31%
$741.99M

ABCL Institutional Investors: Active Positions

Increased Positions72+46.75%18M+15.91%
Decreased Positions59-38.31%7M-6.55%
New Positions27New11MNew
Sold Out Positions16Sold Out775,526Sold Out
Total Postitions167+8.44%120M+9.36%

ABCL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Baker Bros. Advisors Lp$71,154.009.24%27.53M00%2024-12-31
Baillie Gifford & Co$31,631.004.11%12.24M-658,238-5.11%2024-12-31
Voya Investment Management Llc$27,464.003.57%10.62M00%2024-12-31
Capital World Investors$20,508.002.66%7.93M+8MNew2024-12-31
Prosight Management, Lp$19,000.002.47%7.35M-2M-19.05%2024-12-31
Credit Suisse Ag/$11,755.001.53%4.55M-30,935-0.68%2024-03-31
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame$11,633.001.51%4.5M-90,103-1.96%2024-12-31
Orbimed Advisors Llc$10,807.001.4%4.18M00%2024-12-31
Arrowmark Colorado Holdings Llc$10,612.001.38%4.11M00%2024-12-31
Blackrock, Inc.$10,590.001.38%4.1M+107,951+2.71%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.89SellsBuysStrong BuyBuyHoldSellStrong SellABCLHighAverageLowSeries 4